Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/25380Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Heynemann, Sarah | - |
| dc.contributor.author | Mitchell, Paul | - |
| dc.date | 2020 | - |
| dc.date.accessioned | 2020-11-25T04:54:38Z | - |
| dc.date.available | 2020-11-25T04:54:38Z | - |
| dc.date.issued | 2021 | - |
| dc.identifier.citation | The Australasian journal of dermatology 2021-05; 62(2): e332-e333 | en |
| dc.identifier.uri | https://ahro.austin.org.au/austinjspui/handle/1/25380 | - |
| dc.language.iso | eng | - |
| dc.title | Relevance of sun safety in patients commencing crizotinib for non-small cell lung cancer. | en |
| dc.type | Journal Article | en |
| dc.identifier.journaltitle | The Australasian Journal of Dermatology | en |
| dc.identifier.affiliation | Medical Oncology | en |
| dc.identifier.affiliation | Olivia Newton-John Cancer Wellness and Research Centre | en |
| dc.identifier.doi | 10.1111/ajd.13503 | en |
| dc.type.content | Text | en |
| dc.identifier.orcid | 0000-0003-2205-5320 | en |
| dc.identifier.pubmedid | 33216964 | - |
| local.name.researcher | Mitchell, Paul L R | |
| item.cerifentitytype | Publications | - |
| item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
| item.fulltext | No Fulltext | - |
| item.openairetype | Journal Article | - |
| item.grantfulltext | none | - |
| item.languageiso639-1 | en | - |
| crisitem.author.dept | Medical Oncology | - |
| crisitem.author.dept | Olivia Newton-John Cancer Wellness and Research Centre | - |
| Appears in Collections: | Journal articles | |
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.